These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1974283)

  • 61. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Neuroleptic malignant syndrome--in need of acute care].
    Poutanen O; Kiviniemi P
    Duodecim; 2004; 120(2):163-8. PubMed ID: 15065507
    [No Abstract]   [Full Text] [Related]  

  • 63. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Neuroleptic malignant syndrome--a case report on diagnosis, differential diagnosis and therapy of a life threatening complication of treatment with neuroleptics].
    Staud L; Pflug B
    Psychiatr Prax; 1992 Jul; 19(4):114-8. PubMed ID: 1354879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose.
    Korchia T; Blackman G; Cermolacce M; Richieri R
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30076161
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
    Krull F; Risse A
    Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents.
    Spivak B; Gonen N; Mester R; Averbuch E; Adlersberg S; Weizman A
    Int Clin Psychopharmacol; 1996 Sep; 11(3):207-9. PubMed ID: 8923101
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 69. Is the predisposition to neuroleptic malignant syndrome genetically transmitted?
    Otani K; Horiuchi M; Kondo T; Kaneko S; Fukushima Y
    Br J Psychiatry; 1991 Jun; 158():850-3. PubMed ID: 1678666
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Truong DD; Sczesni B; Fahn S; Gross J; Donovan K; van Bakel A; Wiley MK
    Nervenarzt; 1988 Feb; 59(2):103-9. PubMed ID: 2896306
    [No Abstract]   [Full Text] [Related]  

  • 72. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 73. Neuroleptic malignant syndrome in an afebrile patient on second generation antipsychotics.
    Chee A; Tay KH; Yap PP; Kwok V; Rawtaer I
    Asian J Psychiatr; 2020 Apr; 50():101938. PubMed ID: 32109803
    [No Abstract]   [Full Text] [Related]  

  • 74. Atypical neuroleptic malignant syndrome associated with aripiprazole.
    Kang SG; Lee HJ; Lee MS; Kim L; Park JS
    J Clin Psychopharmacol; 2006 Oct; 26(5):534. PubMed ID: 16974203
    [No Abstract]   [Full Text] [Related]  

  • 75. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuroleptic malignant syndrome with renal and respiratory complications--a case report.
    Liam CK; Ong SB
    Singapore Med J; 1990 Apr; 31(2):182-4. PubMed ID: 1973548
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome.
    Nisijima K; Kusakabe Y; Ohtuka K; Ishiguro T
    Biol Psychiatry; 1998 Nov; 44(9):930-1. PubMed ID: 9807653
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Possible neuroleptic malignant syndrome with quetiapine.
    Stanley AK; Hunter J
    Br J Psychiatry; 2000 May; 176():497. PubMed ID: 10912237
    [No Abstract]   [Full Text] [Related]  

  • 79. Neuroleptic malignant syndrome in the acquired immunodeficiency syndrome.
    Hernández JL; Palacios-Araus L; Echevarría S; Herrán A; Campo JF; Riancho JA
    Postgrad Med J; 1997 Dec; 73(866):779-84. PubMed ID: 9497946
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The (frequently) neuroleptic (potentially) malignant syndrome.
    Kellam AM
    Br J Psychiatry; 1990 Aug; 157():169-73. PubMed ID: 1977485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.